We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WE
8976
DELISTED
WeWork Inc.
WE
$6.29K ﹤0.01%
110
-445
-80% -$41.7K
LNAI
8977
Lunai Bioworks
LNAI
$11M
$6.29K ﹤0.01%
+76
New +$10.2K
EBMT icon
8978
Eagle Bancorp Montana
EBMT
$191M
$6.29K ﹤0.01%
389
-982
-72% -$17.8K
GALT icon
8979
Galectin Therapeutics
GALT
$212M
$6.28K ﹤0.01%
+5,561
New +$7.41K
CAMP
8980
DELISTED
CalAmp Corp.
CAMP
$6.28K ﹤0.01%
61
-100
-62% -$8.45K
PRLD icon
8981
Prelude Therapeutics
PRLD
$373M
$6.26K ﹤0.01%
1,037
+969
+1,425% +$6.21K
CARM
8982
DELISTED
Carisma Therapeutics
CARM
$6.25K ﹤0.01%
513
-2,499
-83% -$26.2K
CHIH
8983
DELISTED
Global X MSCI China Health Care ETF
CHIH
$6.24K ﹤0.01%
377
+215
+133% +$3.25K
ORTX
8984
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$6.23K ﹤0.01%
1,684
+1,303
+342% +$5.76K
BSFC
8985
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
$6.23K ﹤0.01%
16
+3
+23% +$2.26K
SNT
8986
Senstar Technologies
SNT
$43.4M
$6.22K ﹤0.01%
4,933
-69
-1% -$106
WBIF icon
8987
WBI BullBear Value 3000 ETF
WBIF
$23.3M
$6.21K ﹤0.01%
223
SPRB
8988
Spruce Biosciences
SPRB
$128M
$6.21K ﹤0.01%
75
-25
-25% -$2.09K
ROSE
8989
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
$6.2K ﹤0.01%
+601
New +$6.16K
TOMZ icon
8990
TOMI Environmental Solutions
TOMZ
$14.2M
$6.18K ﹤0.01%
4,208
+1,327
+46% +$2.62K
BDTX icon
8991
Black Diamond Therapeutics
BDTX
$110M
$6.18K ﹤0.01%
3,433
-1,942
-36% -$3.5K
JATT.U
8992
DELISTED
JATT Acquisition Corp Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
JATT.U
$6.17K ﹤0.01%
600
RVP icon
8993
Retractable Technologies
RVP
$20.3M
$6.17K ﹤0.01%
3,763
-4,856
-56% -$10.3K
NVAX icon
8994
PUT
Novavax
NVAX
$1.27B
$6.17K ﹤0.01%
+600
New +$10.6K
TARA icon
8995
Protara Therapeutics
TARA
$230M
$6.16K ﹤0.01%
2,300
+2,061
+862% +$6.5K
NSTC.U
8996
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
$6.16K ﹤0.01%
615
-10,250
-94% -$102K
ELTK icon
8997
Eltek
ELTK
$59.5M
$6.16K ﹤0.01%
1,499
+1,457
+3,469% +$5.68K
PSDN
8998
DELISTED
AdvisorShares Poseidon Dynamic Cannabis ETF
PSDN
$6.15K ﹤0.01%
3,995
+3,541
+780% +$8.31K
PWOD
8999
DELISTED
Penns Woods Bancorp
PWOD
$6.15K ﹤0.01%
231
+226
+4,520% +$5.67K
MBBB icon
9000
VanEck Moody's Analytics BBB Corporate Bond ETF
MBBB
$4.72M
$6.14K ﹤0.01%
+300
New +$6.06K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.